Citation advantage of COVID-19-related publications

新冠肺炎相关出版物的引用优势

阅读:1

Abstract

With the global spread of the COVID-19 pandemic, scientists from various disciplines responded quickly to this historical public health emergency. The sudden boom of COVID-19-related papers in a short period of time may bring unexpected influence to some commonly used bibliometric indicators. By a large-scale investigation using Science Citation Index Expanded and Social Sciences Citation Index, this brief communication confirms the citation advantage of COVID-19-related papers empirically through the lens of Essential Science Indicators’ highly cited paper. More than 8% of COVID-19-related papers published during 2020 and 2021 were selected as Essential Science Indicators highly cited papers, which was much higher than the set global benchmark value of 1%. The citation advantage of COVID-19-related papers for different Web of Science categories/countries/journal impact factor quartiles was also demonstrated. The distortions of COVID-19-related papers’ citation advantage to some bibliometric indicators such as journal impact factor were discussed at the end of this brief communication.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。